Hypercalcemia, arrhythmia, and mood stabilizers

Journal of Clinical Psychopharmacology

Volumn 20, Issue 2, 2000, Pages 260-264

  Wolf, Marion E ^a,b   Ranade, Vasant ^c,d   Molnar, Janos ^c,e   Somberg, John ^c,d   Mosnaim, Aron D ^e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c American Institute of Therapeutics   (United States)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM;

ADULT; AGED; ARTICLE; BRADYCARDIA; DISEASE ASSOCIATION; DRUG SAFETY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; HYPERCALCEMIA; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; MORTALITY; PRIORITY JOURNAL;

ADULT; AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; BRADYCARDIA; COMORBIDITY; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERCALCEMIA; LITHIUM CARBONATE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0034035404     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200004000-00022     Document Type: Article

References (29)

1. McHenry CR, Stenger D, Racke F. Investigation of calcium-induced hydrolysis of phosphoinositides in normal and lithium-treated parathyroid cells. Am J Surg 1995;170:484-7.
2. Racke F, McHenry CR, Wentworth D. Lithium-induced alterations in parathyroid cell function: insight into the pathogenesis of lithium associated hyperparathyroidism. Am J Surg 1994;168: 462-5.
3. Saxe A, Gibson G, Silveira E. Effects of long-term lithium infusion on normal parathyroid tissue. Surgery 1995;117:577-80.
4. Wortsman J, Frank S. The QT interval in clinical hypercalcemia. Clin Cardiol 1981;4:487-90.
5. Steckler TL. Lithium and carbamazepine sinus node dysfunction: nine year experience in a psychiatric hospital. J Clin Psychopharmacol 1994;4:336-9.
6. Ranade V, Wolf ME, Mosnaim AD. Developments in antiarrhythmic drugs: an overview. Exp Opin Invest Drugs 1995;4:1-29.
7. Dubovsky SL, Christiano J, Daniell LC, Frank RD, Murphy J, Adler L, Baker N, Harris A. Increased platelet intracellular calcium concentration in patients with bipolar affective disorders. Arch Gen Psychiatry 1989;46:632-8.
8. Bajorunas DR. Clinical manifestations of cancer-related hypercalcemia. Semin Oncol 1990;17:16-25.
9. Nordenstrom J, Elvius M, Bagedahl-Strinlund M, Zhao B, Torring, O. Biochemical hyperparathyroidism and bone mineral status in patients treated long term with lithium. Metabolism 1994;43:1563-7.
10. Kingsbury SJ, Salzman C. Lithium's role in hyperparathyroidism and hypercalcemia. Hosp Community Psychiatry 1993;44:1047-8.
11. Bendz H, Sjodin L, Toss G, Berglund K. Hyperparathyroidism and long term lithium therapy: a cross-sectional study and the effect of lithium withdrawal. J Intern Med 1996;240:357-65.
12. Ljunghall S, Hellman P, Rastad J, Akerstrom G. Primary hyperparathyroidism: epidemiology, diagnosis and clinical picture. World J Surg 1991;15:681-7.
13. Potts JT. Hyperparathyroidism and other hypercalcemic disorders. Adv Intern Med 1996;41:165-212.
14. Pecherstorfer M, Schilling T, Blind E, Zimmer-Roth I, Baumgartner G, Ziegler R, Raue F. Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patients. J Clin Endocrinol Metab 1994;78:1268-70.
15. Warrel RP, Israel R, Frisone M, Snyder T, Gaynor JJ, Bockman RS. Gallium nitrate for acute treatment of cancer-related hypercalcemia: a randomized, double-blind comparison of calcitonin. Ann Intern Med 1988;108:669-74.
16. Ralston SH, Gallacher SJ, Patel U, Campbell J, Boyle IT. Cancer-associated hypercalcemia: morbidity and mortality. Ann Intern Med 1990;112:499-504.
17. Hutchesson ACJ, Bundred NJ, Ratcliffe WA. Survival in hypercalcemic patients with cancer and co-existing primary hyperparathyroidism. Postgrad Med 1995;71:28-31.
18. Wolf ME, Moffat M, Mosnaim JM, Dempsey S. Lithium therapy, hypercalcemia and hyperparathyroidism. Am J Ther 1997;4:323-6.
19. Fish C. The normal electrocardiogram. In: Braunwald E, ed. Heart disease: a textbook of cardiovascular medicine. 3rd ed. Philadelphia: Saunders, 1988:183-7.
20. Fish C. The abnormal electrocardiogram and vectocardiogram. In: Braunwald E, ed. Heart disease: a textbook of cardiovascular medicine. 3rd ed. Philadelphia: Saunders, 1988:189-222.
21. Mitchell JE, Mackenzie TB. Cardiac effects of lithium therapy in man: a review. J Clin Psychiatry 1982;43:47-51.
22. Roose SP, Bone S, Haidorfer C, Dunner DL, Fieve RR. Lithium treatment in older patients. Am J Psychiatry 1979;136:843-4.
23. Landrum-Michalets E, Smith LK, Van Tassel ED. Torsade de pointes resulting from the addition of droperidol to an existing cytochrome p450 drug interaction. Ann Pharmacother 1998;32: 761-5.
24. Baker B, Dorian P, Sandor P, Shapiro C, Schell C, Mitchell J, Irvine MJ. Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder. J Clin Psychopharmacol 1997;17:15-21.
25. Lawrence KR, Nasraway SA. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature. Pharmacotherapy 1997;17: 531-7.
26. Wolf ME, Moffat M, Ranade V, Somberg J, Lehrer E, Mosnaim AD. Lithium, hypercalcemia and arrhythmia [letter]. J Clin Psychopharmacol 1998;18:420-3.
27. Kasarkis EJ, Kuo CS, Berger R, Nelson KR. Carbamazepine-induced cardiac dysfunction. Arch Intern Med 1992;152:186-91.
28. Kenneback G, Bergfeldt L, Tomson O, Spina E, Edhag O. Carbamazepine induced bradycardia: a problem in general or only in susceptible patients? A 24-h long-term electrocardiographic study. Epilepsy Res 1992;13:141-5.
29. Craig CR. Anticonvulsant drugs. In: Craig CR, Stitzel RE, eds. Modern pharmacology, 4th ed. New York: Little, Brown and Co., 1994:413-24.